Aflac Incorporated (NYSE:AFL) Stock Position Cut by Boston Family Office LLC

Boston Family Office LLC decreased its stake in shares of Aflac Incorporated (NYSE:AFL) by 0.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,397 shares of the financial services provider’s stock after selling 200 shares during the period. Boston Family Office LLC’s holdings in Aflac were worth $2,213,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in AFL. Geode Capital Management LLC increased its stake in shares of Aflac by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 12,465,433 shares of the financial services provider’s stock valued at $1,286,042,000 after acquiring an additional 288,482 shares during the period. Tradewinds LLC. bought a new position in Aflac during the 4th quarter valued at $476,000. National Bank of Canada FI increased its position in shares of Aflac by 0.9% during the 4th quarter. National Bank of Canada FI now owns 348,998 shares of the financial services provider’s stock valued at $36,111,000 after purchasing an additional 3,195 shares during the period. Family Legacy Inc. raised its stake in shares of Aflac by 4.3% in the 4th quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider’s stock worth $270,000 after buying an additional 107 shares in the last quarter. Finally, Summit Financial LLC lifted its holdings in shares of Aflac by 0.6% in the fourth quarter. Summit Financial LLC now owns 19,269 shares of the financial services provider’s stock valued at $1,993,000 after buying an additional 123 shares during the period. 67.44% of the stock is currently owned by institutional investors.

Aflac Trading Up 1.3 %

Shares of NYSE AFL opened at $111.25 on Tuesday. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The business has a 50-day moving average price of $106.58 and a two-hundred day moving average price of $107.68. The firm has a market capitalization of $60.72 billion, a PE ratio of 11.59, a PEG ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on AFL shares. BMO Capital Markets began coverage on Aflac in a report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 target price on the stock. Wells Fargo & Company lowered their price objective on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 19th. Piper Sandler reduced their target price on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Keefe, Bruyette & Woods dropped their price target on Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a report on Wednesday, February 12th. Finally, JPMorgan Chase & Co. raised their price objective on Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 7th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $103.36.

Insider Buying and Selling at Aflac

In other news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now directly owns 49,962 shares in the company, valued at $5,360,422.98. The trade was a 37.36 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares in the company, valued at $2,733,048.59. This represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.